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10 ABSTRACT: Artemisia dracunculus L. (tarragon) has a long history of use as a spice and remedy. Two well-described
11 “cultivars” (Russian and French) are used widely and diﬀer in ploidy level, morphology, and chemistry. Key biologically active
12 secondary metabolites are essential oils (0.153.1%), coumarins (>1%), ﬂavonoids, and phenolcarbonic acids. In vivo studies
13 mainly in rodents, particularly fromRussian sources, highlight potential anti-inﬂammatory, hepatoprotective, and antihyperglycemic
14 eﬀects. Despite concerns about the toxic eﬀects of two of its main constituents, estragole (up to 82%) and methyleugenol
15 (up to 39%), no acute toxicity ormutagenic activity has been reported at doses relevant for human consumption.Water extracts ofA.
16 dracunculus contain very low amounts of estragole and methyleugenol and, therefore, are considered to pose a very limited risk.
17 Overall, a stronger focus on clinical studies and precise taxonomic and phytochemical deﬁnition of the source material will be
18 essential for future research eﬀorts.
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23 ’ INTRODUCTION
24 Artemisia dracunculus L. (tarragon) is a perennial herb in
25 the Asteraceae (daisy) family, which has a long history of use
26 in culinary traditions. It also possesses a wide range of health
27 beneﬁts and has therefore been widely used as a herbal
28 medicine. The botany and chemical constituents are well de-
29 scribed in the literature, the latter mainly focusing on its
30 essential oil composition that determines its distinct ﬂavor.
31 Additionally, a wide range of secondary metabolites (ﬂavo-
32 noids, phenylpropanoids, coumarins, etc.) are reported, deter-
33 mining A. dracunculus biological activities and its potential use
34 as a source for plant-derived pharmaceutical chemical entities
35 and complex extracts.
36 The goal of this paper is to review existing knowledge of
37 A. dracunculus’s phytochemical composition, its uses in local
38 medicine, and reported in vitro and in vivo pharmacological
39 studies on plant-derived extracts and also to highlight the potential
40 for developing evidence-based A. dracunculus preparations. Due to
41 taxonomic ambiguities, an understanding of the source material
42 used in reviewed studies is crucial.8,10,16,17,21 Signiﬁcant diﬀerences
43 in phytochemical proﬁle and pharmacological properties between
44 diﬀerent varieties occur.12,13,71 French tarragon (sometimes
45 called German tarragon) and Russian tarragon are the two main
46 reported cultivars for this species. Whereas French tarragon is
47 well described in the recognized Western scientiﬁc literature,
48 considerable information on Russian tarragon is covered in
49 Russian publications only. All available literature has been
50 compared accordingly in this review.
51The speciﬁc epithet dracunculus (Latin meaning “little dragon”)
52is believed to describe its coiled, serpentine root and/or the
53shape of the leaves, which is reminiscent of a dragon's tongue.1,2
54Tarragon’s common names include Tarkhun (Arabic, Russian),
55ai hao (Mandarin), estragoa (Dutch), dragon (Dutch, Swedish),
56estragon (French, German, Italian, Norwegian, Russian), tarragon
57(Hebrew), estragon (Spanish), targone (Italian), esutoragon
58(Japanese), and estragao (Portugese).
59A. dracunculus is described in several well-recognized herbal
60reference texts from the 17th to the 19th centuries, where authors
61indicate the species’ appearance, distribution, and, importantly,
62local and traditional medicinal uses. However, it is not included
63in earlier herbals. Gerard’s Herbal or General History of Plants3
64makes reference to tarragon’s culinary beneﬁts and use as a spice
65in Europe, whereas Culpepper4 highlights its application in uro-
66genital system malfunctioning. In addition, Dragendorﬀ,5 in his
67synopsis aboutmedicinal herbs, describesA. dracunculus as amiddle
68European spice plant containing estragole-rich essential oil with
69antiscurvy (antiscorbutic), antiarthritic, and other health beneﬁts.
70A. dracunculus’s distribution spans over westernNorth America,
71eastern and central Europe, and most of temperate Asia.6 The
72species is widely cultivated across the world, mainly in southern
73Europe, Russia, and the United States.8,23,28,57
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74 ’TAXONOMY AND KARYOTYPES
75 A. dracunculus is characterized by a wide range of morpho-
76 logical and phytochemical variability, which is associated with
77 diﬀerent geographical origins of the samples studied. Addi-
78 tionally, polyploidy is notably common, and reported cyto-
79 types diﬀer in external morphology, anatomy, fertility, and
80 phytochemical constituents and also diﬀer cytogenetically.69
81 Thus, the existing literature lacks a common approach to the
82 species’ taxonomic classiﬁcation, with some authors classify-
83 ing French tarragon and Russian tarragon as subspecies,
84 varieties, or even species (Table 1T1 ).
85 Variable levels of polyploidy have been reported, which appear
86 to correlate with the divergent phytochemical proﬁles of diﬀerent
87 samples and, hence, inconsistencies in the taxonomic classiﬁca-
88 tions. A. dracunculus, like the majority of Artemisia species, has a
89 base chromosome number of x = 9, but it is also polyploid (2n =
90 2x = 18; 2n = 3x = 27; 2n = 4x = 36; 2n = 6x = 54, 2n = 8x = 72,
91 2n = 10x = 90).6,10,11 Diﬀerent cytotypes of the species express
92 divergent phytochemical proﬁles. Therefore, knowledge of the
93 origin of the source material is essential when the species’ bio-
94 activity or chemistry is studied. A. dracunculus’s diploid cytotype
95 is widely distributed and can be found across Asia and North
96 America, whereas wild tetraploids are found in Europe and Asia. In
97 contrast, hexaploids appear to have a more restricted distribution
98 in eastern Europe. Due to the complex distribution ofA. dracunculus
99cytotypes, standardization of plant material becomes extremely
100important when medicinal applications are investigated.6,10
101From a systematic/taxonomic perspective two main “varieties”
102or “cultivars” are recognized, French tarragon and Russian or wild
103tarragon (Russian tarragon). French tarragon is believed to be a
104sterile tetraploid and has to be propagated clonally, whereas
105Russian tarragon characteristically has a range of cytotypes, which
106vary depending on the origin of the samples.6,10 Both have been
107cultivated, and French tarragon is believed to have originated
108from Russian tarragon by means of selection.7,12,13,15 It is note-
109worthy that botanical systematic textbooks of the USSR do not
110make reference to French tarragon but distinguish six varieties
111of A. dracunculus, distributed throughout the territory of the
112former Soviet Union.15 Furthermore, other regional “varieties”
113(Italian, Polish, Iranian, American), distinguished by essential oil
114composition, are described in the literature.1720 Nonetheless,
115according to current botanical classiﬁcation,A. dracunculusL. is not
116separated into subspecies.23
117’CULINARY USE
118French tarragon has a cool, sweet, licorice-like aroma with
119slight bitter tones. Its taste is herbaceous, with anise- and basil-
120like notes, and it is considered to be more delicate than the
121Russian tarragon. Russian tarragon has larger leaves, lacks the
122anise-like taste, and is slightly bitter and harsh in ﬂavor.
Table 1. Synonyms Used for the Main Tarragon Cultivars
synonyms
French tarragon Russian tarragon ref
A. dracunculus f. dracunculus L. A. dracunculus f. redowskii hort 17
French Tarragon (described as cultivars) 8
German Tarragon
A. dracunculus var. sativa Besser A. dracunculus var. dracunculus 10
A. dracunculus (authors not speciﬁed) A. dracunculoides (authors not speciﬁed) 7
A. dracunculus var. sativa (authors not speciﬁed) A. dracunculus var. dracunculus (authors not speciﬁed) 21
(not stated) A. dracunculus var. pratorum Krasch. 16
A. dracunculus var. turkestanica Krasch. Krasc
A. dracunculus var. pilosa Krasch.
A. dracunculus var. humilis Kryl.
A. dracunculus var. Redovskyi Ldb
Artemisia aromatica A. Nelson 22a
A. dracunculina S. Watson
A. dracunculoides Pursh
A. dracunculoides subsp. dracunculina (S. Watson) H. M. Hall &
Clements; A. glauca Pallas ex Willdenow
A. glauca var. megacephala B. Boivin
Artemisia redowskyi Ledeb 95a
Oligosporus condimentarius Cass.
Oligosporus dracunculus L. Polj.
Artemisia inodora Willd.
Artemisia dracunculus L. Artemisia dracunculus, numerous varieties 106
a In case of references 22 and 95 no distinction between Russian or French origin is made.
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Table 2. Constituents of A. dracunculus
class compound ref
ﬂavonoids (ﬂavones, ﬂavanones, dihydroﬂavanols, chalcones) 5,6,7,8, 40 -pentahydroxymethoﬂavone 1, 13, 4648, 106
estragoniside
7-O-β-D-glycopyranoside 5,7-dihydroxyﬂavavone
pinocembrin
7-O-β-D-glucopyranoside
luteolin
quercetin
rutin
kaempferol
annangenin
5,7-dihydroxyﬂavone
naringenin
3,5,40 -trihydroxy-7-methoxyﬂavanone
3,5,4 -trihydroxy-7,30-dimethoxyﬂavanone
20 ,40-dihydroxy-4-methoxydihydrochalcone
davidigenin
sakuranetin
phenylpropanoids chicoric acid 13,48,106
hydroxybenzoic acid
(E)-2-hydroxy-4-methoxycinnamic
chlorogenic acid
caﬀeic acid
5-O-caﬀeoylquinic acid
4,5-di-O-caﬀeoylquinic acid
chromones/coumarins herniarine 1, 42, 49, 50, 5254, 106
()-(R)-20-methoxydihydro-artemidin
(+)-(S,R)-epoxyartemidin
dracumerin
(+)-(R)-(E)-30-hydroxyartemidin
capillarin isovalerate
7,8-methylenedioxy-6-methoxycoumarin
γ,γ-dimethylallyl ether of esculetin
scopoletin
scoparone
daphnetin methylene ether
daphnetin 7-methyl ether
artemidiol
4-hydroxycoumarin
artemidin
artemidinal
artemidinol
esculin
capillarin
8-hydroxycapillarin
8-hydroxyartemidin
6-demethoxycapillarisin
alkamides pellitorine 52
neopellitorine A
neopellitorine B
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123 Fresh aerial parts are used whole, chopped, or minced, and
124 when dried, tarragon is used whole, crushed, or ground. Some-
125 times the stems are included with the leaves. In Europe,
126 A. dracunculus is popularly used to ﬂavor many sauces, and it is
127 a favorite herb in France and characterizes French Dijon mustard
128 and sauces based on sour cream, eggs, and mayonnaise, such as
129 tartar, bearnaise, and hollandaise. It is also used in cream soups,
130 salads, omelets, and gravies. These sauces are often added to
131 broiled, baked, or fried ﬁsh, meat, and chicken.2
132 Armenians use tarragon on vegetables and ﬁsh and meat
133 dishes. In the United States it is used in vinegar, tartar sauce,
134 eggs, chicken, and seafood. Cooking intensiﬁes and changes its
135 ﬂavor, so it is usually added to a dish toward the end of cooking
136 to retain its characteristic aroma and taste.23 In Slovenia,
137 A. dracunculus is used as a spice for a sweet pastry called potica.24
138 A. dracunculus is also used to ﬂavor a popular sweet nonalco-
139 holic drink in Azerbaijan, Armenia, Georgia, Estonia, Russia, and
140 Ukraine that gained popularity in 1980s and is still well-known.
141 This “Tarkhun” is based on a syrupmade fromA. dracunculus, but
142 artiﬁcial coloring is commonly used in commercial drinks,
143 determining its distinct green color.25
144 ’USE IN LOCAL AND TRADITIONAL MEDICINE
145 In traditional medicine A. dracunculus is commonly used to
146 improve a malfunctioning digestive system by increasing appe-
147 tite, to ﬂush toxins from the body, and as a digestive stimulant,
148 especially in cultures with a high consumption of (red) meat.1,2
149 Arabic cultures have used A. dracunculus to treat insomnia and to
150 dull the taste of medicines. Additionally, A. dracunculus has also
151 been used as an anesthetic for aching teeth, sores, and cuts. A.
152 dracunculus has been used widely in central Asia and Russia for
153 the treatment of skin wounds, irritations, allergic rashes, and
154 dermatitis.26 In the traditional medicine of Azerbaijan tarragon
155 was used as an antiepileptic, laxative, antispasmodic, and carmi-
156 native remedy (an infusionmade from a teaspoon of its twigs was
157 consumed an hour before meals).27,28 A. dracunculus has also
158 been used in the traditional medicine in India, including Ladakh,
159 the northern district of Jammu and Kashmir, where an extract of
160 the whole herb was used as vermifuge and to treat various
161 fevers.29 Additionally, A. dracunculus has a long history of use
162 by Native Americans. The Chippewa used the root as a gyneco-
163 logical aid to reduce excessive ﬂow during the menstrual cycle
164 and to aid in diﬃcult labor. The leaves of A. dracunculus were
165 chewed for heart palpitations, and the root was used to make a
166 bath for strengthening children and in steambaths for strength-
167 ening elders. Similarly, the Shuswap used the plant as a gyneco-
168 logical aid during childbirth and also burned A. dracunculus to
169 repel mosquitoes, whereas the Ramah Navajo made a lotion to
170 aid in healing cuts.3032 A. dracunculus is also widely used as a
171 herbal remedy in an extensive range of conditions in traditional
172 medicine in the territory of the former Soviet Union. The main
173 reported therapeutic uses are for the nervous (mitigative, anti-
174 epileptic), digestive (appetite stimulation, spasmolytic, laxative), and
175renal systems (diuretic action); for liver function (choleretic); and
176as anti-inﬂammatory (wound healing, antiulcer), anticancer, and
177antibacterial agents.3337
178’MORPHOLOGY
179A. dracunculus is a woody, perennial subshrub with stem
180heights ranging from 40 to 150 cm. Aerial stems arise from thick,
181horizontal rhizomes growing in clusters and singly. Leaves are
182alternate, 1.28.0 cm long and 16 mm wide. Basal leaves are
183cleft with one to three lobes. The inﬂorescence is a panicle with
184numerous ﬂowers. The outer ﬂorets are pistillate and fertile, the
185central ﬂowers are sterile, and the ovaries are abortive. The seeds
186are achenes. Seed size is approximately 1.5 mm in length3840
187’MORPHOLOGICAL CHARACTERISTICS OF RUSSIAN
188AND FRENCH TARRAGONS
189In general, Russian tarragon is taller than French tarragon and
190the leaves are usually more intensely green. The leaves of both are
191characterized by having secretory structures, glandular hairs, and
192secretory cavities that produce essential oils. This oil is extruded
193when the leaf is physically injured, even in very young leaves,
194through natural ruptures of the elevated hair cuticle.
195A great similarity in the structure of the glandular hairs exists
196among diﬀerent A. dracunculus “cultivars”. All glandular hairs are
197biseriate, with a head consisting of several pairs of cells. The
198secretary substances of these hairs accumulate in a subcuticular
199space and are released with a cuticle rupture. In both French
200tarragon and Russian tarragon the glandular hairs are sparsely
201distributed and cannot be responsible for the large amount of
202essential oil extracted from the leaves. Therefore, the secretary
203cavities must be the main source of extracted essential oils.
204The observed diﬀerences in morphology of secretary structures
205of Russian tarragon and French tarragon are very minor, where-
206by the diverse compositions of essential oils of these two
207“cultivars” are understood to be linked to diﬀerent biosynthesis
208mechanisms.7,9
209’BIOACTIVE CONSTITUENTS
210The most important groups of biologically active secondary
211metabolites in A. dracunculus essential oil are coumarins, ﬂavo-
212noids, and phenolic acids. Most research attention has been
213directed to the composition of the essential oil, its dynamics, and
214variability.19,40,41 However, a number of papers have addressed
215polyacetylene derivatives and ﬂavonoids. Additionally, sesquiter-
216penoids, vitamins, and tanning substances have also been
217reported.4345 Reported bioactive constituents of A. dracunculus
218are outlined in Table 2 T2, and the structures of the main repre-
219sentative compounds are shown in Figure 1 F1.
220Essential Oil. The composition of the essential oil is char-
221acterized by significant variation depending on the ecological
222niche occupied. Additionally, sample cytotype is vital in deter-
223mining essential oil characteristics. Studies of the dynamics of
Table 2. Continued
class compound ref
benzodiazepinesa delorazepame 44
temazepame
aTrace amounts claimed to be produced by the cell culture.
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224 essential oil accumulation during ontogenesis showed that there
225 are two peaks of oil content during the process of plant growth
226 and development, at the beginning of budding and at the start of
227 flowering.1 Chemical “varieties” of the species have been identi-
228 fied in terms of the qualitative composition of the essential oil.
229 The contents of the essential oil are usually 0.153.1% in the
230 aerial part, and themain components are nonterpenoid compounds:
231 aromatic and acetylene compounds, isocoumarin derivatives, and
232 fatty acids.15,19,20,41,42,5558 Notably, major components of the
233 essential oil diﬀer signiﬁcantly depending on the origin of the
234 material (Tables 3T3 and 4). Methyleugenol (up to 39%), estragol
235 (up to 82%),T4 elemicin (up to 57%), and terpinolene (up to 25%) are
236 reported to be the prevalent constituents among various regional
237 “varieties” (Tables 3 and 4).
238The diﬀerences in essential oil composition between Russian
239tarragon andFrench tarragon have been reported by several authors.
240The major components of Russian tarragon are reported to be
241terpinen-4-ol, sabinene, and elemicin. Methyleugenol and estragole
242are usually present at about 10 and 3%, respectively. However,
243estragole is one of the predominant compounds in French tarragon
244essential oil, with up to 82% presence. Additionally, 7-methoxycou-
245marin and β-ocimene usually appear at about 10%. Importantly, the
246content of the main essential oil constituents depends heavily on
247harvesting time. It was shown that the quantity of estragole could
248rise more than twice compared to samples of Russian tarragon
249collected at the end of June or at the end of July. On the other hand,
250amounts of methyleugenol are normally higher at the beginning of
251summer.106
Figure 1. Representative constituents from A. dracunculus.
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252 Coumarins. A. dracunculus usually contains >1.0% coumarins,
253 with maximal accumulation usually observed during the generative
254 period, whereas the composition remains stable during this time.
255 Coumarins identified include herniarin, coumarin, esculetin, esculin,
256 capillarin, 8-hydroxycapillarin, artemidin, 8-hydroxyartemidin, arte-
257 midinol, and others.1,5052
258 Peroxidase and Nitrogen Bases. Roots, stems, leaves, and
259 inflorescences contain the enzyme peroxidase.1 Although the
260 exact mechanisms have yet to be elucidated, peroxidases are
261 known to play a part in increasing a plant’s defenses against
262 pathogens. Correlational relationships were found between
263 peroxidase activity and the maximal accumulation of phenol
264 compounds. Peroxidase is able to manifest peroxidase activity (at
265 pH 5.2) and oxidase activity (at pH 7.08.5).1 Minimal condi-
266 tions for the appearance of oxidase activity are the presence of
267 two hydroxyl groups in the ortho-position and the absence of a
268 carboxyl group as a substituent in the benzene ring.
269 The potential application of peroxidase isolated from
270 A. dracunculus could be similar to that of horseradish peroxidase,
271 which is used extensively in molecular biology for antibody
272 detection and in immunohistochemistry for labeling of tissue
273 sections. Additionally, peroxidase can be used in the treatment of
274 industrial waste waters. Enzyme-catalyzed polymerization using
275horseradish peroxidase can remove phenols, which are important
276pollutants. Phenols are oxidized to phenoxy radicals, which
277convert to polymers and oligomers that are less toxic, and have
278been used in many manufacturing processes such as for adhe-
279sives, computer chips, car parts, and linings of drums and cans.
280Some studies44 have addressed nitrogen-containing substan-
281ces in A. dracunculus, and an extract of tissue cultured cells
282was found to have positive inﬂuences on human brain benzo-
283diazepine receptors. High-performance liquid chromatography
284separation of the extract produced benzodiazepine derivatives,
285which were identiﬁed as delorazepam and temazepam, the levels
286of which in the cellular tissues reached 0.10.2 μg/g of cell
287culture.44 Nitrogenous bases were extracted from the above-
288ground parts of the plant: a previously studied compound,
289pellitorin, and two new compounds, neopellitorin A and neo-
290pellitorin B, were shown to possess insecticidal activity.52
291’BIOLOGICAL ACTIVITY AND PHARMACOLOGICAL
292PROPERTIES
293Extracts and some individual compounds of A. dracunculus are
294reported to possess a wide range of pharmacological properties
295including antibacterial, antifungal, anti-inﬂammatory, antidia-
296betic, hepatoprotective, gastroprotective, and anticonvulsant
297activities. Aside from a number of in vitro experiments, a
298considerable number of in vivo studies have been conducted
299evaluating a wide spectrum of health beneﬁts. Importantly, the
300antihyperglycemic action of extracts has been assessed exten-
301sively in animal models, and antidiabetic formulations and
302increased bioavailability have been developed.13,6063 An exten-
303sive number of pharmacological activities of Russian tarragon
304were explored in vivo and reported in Russian scientiﬁc literature,
305which is also summarized in the present review (Table 5 T5).
306’ IN VITRO PHARMACOLOGICAL ACTIVITIES OF
307TARRAGON
308Antibacterial Activity. The antimicrobial activities of chloro-
309form, acetone, and methanol as well as water extracts of
310A. dracunculus have been widely studied,12,13,64,65 showing a wide
311variety of antimicrobial activity against pathogenic microorgan-
312isms, including inhibition of growth of Staphylococcus aureus,
313Pseudomonas aeruginosa, Shigella (RSHI), Listeria monocytogenes,
314Staphylococcus epidermidis, Bacillus subtilis, and others. Addition-
315ally, Kordali et al.42 described the antibacterial potential of A.
316dracunculus essential oil against Pseudomonas syringae glycinea
317(RK-470), Xanthomonas axanopodas pv vesicatoria, Brevibacter-
318ium casei, Proteus vulgaris, and others. The bactericidal activity of
319water A. dracunculus extract on Helicobacter pylori was reported,
320highlighting the potential of A. dracunculus preparations as a
321treatment for gastroduodenal diseases, including gastric and
322duodenal ulcers.65
323Antifungal Activity. A. dracunculus essential oil has been
324reported to possess moderate antifungal activity against a num-
325ber of species including Phythium ultimum, Sclerotinia sclerotior-
326um, Botrytis sp., Fusarium seminectum, Colletrotichum fragariae,
327Colletrotichum gloeosporioides, and Colletrotichum acutatum.42,54
328This provides a basis for possibly developing A. dracunculus
329preparations for use against agricultural pathogenic fungi.
330Antiplatelet Activity. Platelet hyperactivity is one of the most
331important factors responsible for arterial thrombosis and athero-
332sclerosis. One important mechanism by which blood platelets
Table 3. Reported Prevalent Constituents (>10%) of Essential
Oil of A. dracunculus
origin of A. dracunculus major essential oil constituents
Russian tarragon methyleugenol (up to 14%)
terpinen-4-ol (up to 41.34%)
sabinene (up to 39%)
elemicin (up to 57%)
β-ocimene (up to 12%)
estragole (up to 3.39%)
French tarragon estragole (up to 74%)
7-methoxy coumarin (up to 13%)
β-ocimene (up to 10%)
methyleugenol (up to 5%)
Georgia estragole (up to 82%)
Canada methyleugenol (up to 35%)
terpinolene (up to 19.1%)
estragole (up to 16.2%)
Denmark methyleugenol (up to 39%)
sabinene (up to 24.75%)
elemicin (up to 10.37%)
United States terpinolene (up to 25%)
cis-ocimene (up to 22.2%)
Iran α-trans-ocimene (up to 20%)
limonene (up to 12%)
Cuba methyleugenol (up to 17%)
Italy trans-anethole (up to 53%)
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Table 4. Major Essential Oil Components (> 1% of Total
Essential Oils) of A. dracunculus
compound origin amount (%) ref
α-pinene Iran 5.1 19
azarone NS 40.36 59
Russia 21.69 12
limonene France 6.98 12
NS 6.33 59
Georgia 2.40
terpinolene Iran 12.4 19
Turkey 3.1 42
France 2.26 7
Canada 1.1 20
central Italy 7.26 58
United States 25.4 18
phytol Canada 19.1 20
France 1.41 12
allo-ocimene Iran 4.8 19
cis-ocimene United States 22.2 18
cis-allo-ocimene central Italy 10.61 58
Russia 2.65 15
central Italy 15.27 58
tetradecanoic acid Russia 2.12 12
n- hexadecanoic acid France 2.84 12
Russia 9.51 12
trans-ocimene France 7.74 12
United States 7.0 18
α-trans-ocimene central Italy 8.96 58
Russia 2.99 15
Iran 20.6 19
7-methoxycoumarin France 12.38 12
3,4,7-trimethoxycoumarin Russia 3.89 12
6,7-dimethoxycoumarin France 7.32 12
Russia 12.07 12
β-ocimene France 5.66 12
Turkey 9.6 42
trans-anethole France 10.00 7
USSR/Russia 12.65 7
Canada 12.4 20
Iran 21.2 19
Table 4. Continued
compound origin amount (%) ref
(Z)-anethole central Italy 53.37 58
Turkey 81.0 42
hexadecenoic acid Russia 2.89 12
9-octadecenoic acid Russia 2.13 12
methyleugenol Iran 2.2 19
Georgia 1.24 106
Denmark 39.35 106
Russia 3.39 106
methylisoeugenol United States 7.0 18
Turkey 1.8 42
USSR/Russia 6.27 7
Canada 35.8 20
Albania ∼9.0 55
Cuba 17.61 57
Russia 13.77 12
France 4.84 12
France 8.50 14
Russia 14.72 14
Russia 1.75 12
Denmark 1.87 106
germacrene D France 1.7 12
Canada 1.4 20
germacrene D-4-ol Georgia 1.52 106
Denmark 1.41 106
squalene Russia 8.60 12
France 4.65 12
3,7-dimethyl-1,3,7-octatriene NS 38.43 59
1-methoxy-4-(2-propenyl)
benzene
NS 8.57 59
capillarin Albania ∼4 55
spathulenol France 1.16 12
estragole (p-allylanisole,
methylchavicol)
Russia 2.74 15
France 74.46 7
Canada 16.2 20
France 28.3 13
France 68.80 14
Georgia 82.06
Denmark 1.08
α-chimachalene Cuba 1.59 57
capillene (6-phenyl-2,4-
hexadiyne)
United States 4.8 18
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333 perform their functions is adhesion to the injured vessel wall,
334 which may be regarded as a crucial and complex step of
335 hemostatic process. Shahriyary66 showed the antiaggregatory
336potential of A. dracunculus leaves. The extract effectively inhib-
337ited platelet adhesion, aggregation, and protein expression
338induced by thrombin, which provides further scientific evidence
339for traditional use of this species in the treatment of thrombotic
340disorders.
341’ IN VIVO PHARMACOLOGICAL ACTIVITIES OF
342TARRAGON
343Anti-inflammatory Activity. Ethanol extracts of A. dracunculus
344were shown to possess considerable antiexudative activity.12,68
345Crude ethanol extracts (40 and 70%) of A. dracunculus reduced
346formalin and adrenalin edemas in rats up to 80%. A 70% ethanolic
347extract was shown to have potent anti-inflammatory action, stronger
348than that of phenylbutazone.
349Hepatoprotective Activity. The hepatoprotective activity of
350tarragon crude ethanol extract was studied in animal models of
351subacute tetrachloromethane-induced hepatitis in rats. Consid-
352erable reduction of the necrosis area (by at least 30%) was
353observed in animals that were given 70% ethanol extract.
354Additionally, after introduction of A. dracunculus extracts in
355rats, segments of liver parenchyma contained more hepatocytes
356without any signs of dystrophy. It was concluded that
357A. dracunculus extracts strengthen cell membrane and enhance
358compensatory mechanisms of hepatocytes and, hence, increase
359resistance to stress factors.12,68
360Antihyperglycemic Action. The antihyperglycemic activity of
361A. dracunculuswas first described by Swanston-Flatt,72 who reported
362that A. dracunculus significantly reduced hyperphagia and polydipsia
363in streptozotocin diabetic mice as well as enhanced body weight
364loss.72 Interestingly, the authors noted the treatment did not
365significantly alter plasma glucose or insulin concentrations. Conse-
366quently, the ability of tarragon to reduce plasma glucose levels
367has been shown in a number of different in vitro and in vivo
368models.45,62,67,73 In vivo tests showed that A. dracunculus prep-
369arations possess antihyperglycemic properties in models with
370exogenous glucose challenge (oral glucose tolerance test) and
371adrenaline-induced hyperglycemia as well as in toxin-induced
372diabetes models (alloxan- and streptozotocin-induced).61,68
373In addition, an ethanolic extract of A. dracunculus (Tarralin)
374was studied extensively and shown to lower plasma glucose levels
375in KK-Aγ mice (genetic diabetes).61 In vitro experiments con-
376cluded that Tarralin increases glucose takeover in muscles
377and enhances the activity of intracellular kinases, induced by
378insulin.63 Additionally, it escalates the binding of incretin
379(GLP-1, glucagon-like peptide-1) with its receptor,61 thus exhi-
380biting insulin-mimetic activity. Moreover, Tarralin causes down-
381regulation of phosphoenolpyruvate carboxykinase (PEPCK) by
382reducing the amount of mRNA for this enzyme and also inhibits
383the activities of tyrosine phosphatase-1B (PTP-1B) and aldose
384reductase type 2 (ALR2).45,61,67 The antidiabetic potential of
385the Tarralin extract has been associated with the presence of
386six compounds: 4,5-di-O-caﬀeoylquinic acid, davidigenin, 6-de-
387methoxycapillarisin, 20,40-dihydroxy-4-methoxydihydrochalcone,
3885-O- caﬀeoylquinic acid, and sakuranetin, found by activity-guided
389isolation.10,45
390To summarize, the mechanism of the antidiabetic action of A.
391dracunculus is pleiotropic and is associated with increased glucose
392utilization in tissues by ampliﬁcation of the endogenous insulin,
393suppression of gluconeogenesis (blockade of PEPCK), and
394possible cytoprotective action (blockade of ALR2).
Table 4. Continued
compound origin amount (%) ref
elemicin USSR/Russia 17.16 7
Cuba 53.03 57
Russia 27.33 15
Russia 15.97 14
Denmark 10.37 106
Russia 57.21 106
geranyl acetate USSR/Russia 1.47 7
sabinene Russia 39.44 14
Denmark 24.75 106
Russia 14.28 106
methyl hexadecanoate France 2.09 12
5-phenyl-1,3-pentadiyne
(1-phenyl-2,4-pentadiyne)
United States 11.7 18
Albania ∼11.0 55
myrcene USSR/Russia 2.69 7
α-phellandrene United States 2.4 18
Russia 1.77 13
β-phellandrene United States 13.1 18
Canada 3.4 20
γ-terpinene France 8.89 7
USSR/Russia 7.52 7
Russia 1.85 14
terpinen-4-ol Cuba 3.95 57
Russia 7.15 14
USSR/Russia 41.34 7
Cuba 4.53 57
Russia 30.10 15
Denmark 1.80 106
Russia 5.41 106
trans-sabinene hydrate Cuba 2.43 57
terpineol USSR/Russia 1.32 7
citronellyl formate USSR/Russia 2.25 7
citronellol Cuba 2.10 57
citronellyl acetate Russia 2.77a 15
isoelemicin Cuba 2.60 57
Russia 6.48 12
France 2.05 12
Denmark 8.15 106
a Seed ripening phase.
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395 Hypolipidaemic Action. Diabetes mellitus is characterized by
396 violation of all types of metabolism including carbohydrate, fat
397 (dyslipidemia, atherosclerosis, obesity), and protein (predominance
398 of catabolism over synthesis) as well as mineral, water, and salt
399 misbalances. Activation of lipid peroxidation plays amajor role in the
400 pathogenesis of atherosclerosis. Additionally, increases in the con-
401 centrations of atherogenic lipoproteins and vascular endothelial
402 damage are also significant factors. Furthermore, hyperlipoprotei-
403 nemia leads to a number of liver disorders. Consequently, hepato-
404 protective, hypoglycemic, antiplatelet, and antioxidant properties of
405 A. dracunculus make the species promising for use as a hypolipo-
406 proteinemic and antiatherosclerotic agent. To date, there is only one
407 paper describing the ability of the aqueous extract of A. dracunculus
408 to reduce total cholesterol and triglyceride plasma, and we believe
409 this topic deserves increased attention.70
410 Antioxidant Activity. The ability of A. dracunculus extracts to
411 reduce accumulation of malonic aldehyde and sialic acid suggests
412 an ability to suppress lipid peroxidation, indicating antioxidant
413 activity.20,68 Additionally, components of A. dracunculus essential
414 oil were shown to exhibit moderate in vitro radical scavenging
415 activity.42,72 Unfortunately, the specific mechanism of action
416 remains unclear and usually falls within the common approach of
417 antioxidant potential of complex mixtures of phenolic com-
418 pounds. Therefore, there is an apparent need for further assay-
419 guided fractionation experiments in the search for individual
420 active compounds.
421 With the properties described above taken into account,
422 further investigations of the species' nootropic, neuroprotective,
423 and anti-ischemic potential as well as inﬂuence on exercise
424 performance would be of important scientiﬁc interest.
425 Antihypoxic Activity. Crude ethanolic extracts of A. dracun-
426 culus also prolonged the life-span and decreasedmortality rates in
427 acute hypobaric anoxia in rats, supporting an antihypoxic activity
428 of A. dracunculus.12 Interestingly, A. dracunculus’s water extracts
429 did not possess such effects.
430 Effects on the Gastrointestinal Tract. Stomach. Gastropro-
431 tective properties were shown to be one of the most prominent
432 effects of A. dracunculus in vivo.12 A. dracunculus ethanolic
433 extracts effectively prevented ulcerogenic effects of phenylbuta-
434 zone in rats. Additionally, Shamsudinov68 reported the ability of
435 water extracts to increase secretion of gastric juice. Whereas A.
436 dracunculus extracts might increase gastric secretion by a reflex
437 mechanism, the gastoprotective action is unlikely to be asso-
438 ciated with coating or antacid effects and most probably is due to
439 activation of protective factors (such as mucin and bicarbonate
440 production), astringent properties, or anti-Helicobacter activity.65
441 Liver. Shamsudinov 68 reported the ability of a dried extract
442 and infusion to significantly lower the activity of hepatic transa-
443 minases (γ-glutamyl transferase, aspartate aminotransferase,
444 alanine aminotransferase) in experimental subacute hepatitis
445 induced by tetrachloromethane.68 In the same experimental
446 model reproduced by Aglarova, injections of A. dracunculus
447 extracts resulted in decreasing dystrophic changes in hepatocytes
448 as well as lowering of the quantity and size of necrotic zones,
449 which were examined in hepatic histological sections.12 The
450 above-mentioned preparations stimulate cholepoiesis and bile
451 secretion in anuran amphibians. Taking into account the safety of
452 the components of its essential oil, which has recently been
453 reported,75 preparations of this species might be used as effective
454 hepatoprotectors, and we believe that comparing A. dracunculus
455 with the other herbal remedies with proven hepatoprotector
456 activities would be scientifically beneficial.
457Neurotropic Activity. Psychosedative. Supilnikova13 reported
458the ability of A. dracunculus extract to prolong thiopental-induced
459sleep in rats.13 However, the doseeffect relationship was of
460the inverse type, and thus challenges the results of the experiment
461(50 mg/kg, duration of sleep +62%; 100 mg/kg, duration of sleep
462+37%). Injections of wateralcohol extracts of the species in
463exploratory behavioral tests (open field and hole-board tests)
464resulted in improved orientation, increased emotional lability, and
465lowered exploratory behavior.12 Kavvadias44 reported the presence
466of benzodiazepines (delorazepam and temazepam) in extracts of
467cultured callus cells ofA. dracunculus in amounts of 0.10.2 μg/g of
468cell culture.44 Although the claim that the cell culture is able to
469produce benzodiazepines needs to be verified independently, these
470compounds cannot be responsible for the sedative properties of
471A. dracunculus as the concentrations of benzodiazepines are too
472low. Additionally, the origin of benzodiazepines in samples of the
473mentioned study remains unclear.
474Analgesic. The ability of French tarragon extract to prolong
475latency periods of nociceptive response and to reduce the
476number of writhes induced by intraperitoneal (ip) injection of
4773% acetic acid (10 mL/kg) supports its effectiveness against
478visceral pain.12 The author hypothesized antagonism to calcito-
479nin gene related peptide (CGRP) as the possible mechanism of
480action of the extract. Thus, the extract of A. dracunculus acted as a
481peripheral analgesic.
482Anticonvulsant. Sayyah19 examined the ability of A. dracunculus
483essential oil to prevent seizures induced by maximal electroshock
484and pentylenetetrazole.19 Moderate anticonvulsant activity was
485shown. However, in the reported study the median effective dose
486(ED50) to obtain anticonvulsant effect was shown to be only twice
487lower than the median lethal dose (LD50), which challenges the
488potential toxicity of its essential oil when used as an anticonvulsant.
489’SAFETY
490The safety of medicinal and spice plants and of their prep-
491arations deserves increased scientiﬁc attention. One of the main
492conditions for use of herbal preparations in medicinal conditions
493is the absence of such risks as mutagenicity, carcinogenicity, and
494teratogenicity. In general, such products need to have minimal
495toxicity and side eﬀects. Generally, the vast majority of herbal
496remedies are recognized as safe, and individual hypersensitivity is
497usually considered as the most common but controllable risk.
498However, for those individual compounds exhibiting toxic eﬀects
499in laboratory animals, the question of possible negative eﬀects in
500humans remains open. In the case of A. dracunculus some
501compounds have come under scrutiny, most importantly, estra-
502gole and methyleugenol.
503Individual Compounds. Estragole (Methylchavicol). Estra-
504gole (1-methoxy-4-allylbenzene) is one of the main components
505of the essential oil of A. dracunculus.76 Estragole is usually the
506dominant constituent, particularly in French tarragon. This
507compound possesses beneficial physiological effects and, conse-
508quently, determines pharmacological effects of this species and
509its preparations. On the other hand, it has been reported that
510estragole is associated with the development of malignant tumors
511in rodents. This was the basis for the recommendations of the
512Scientific Committee on Food (SCF) of the European Union to
513restrict the use of this substance,77 but the potential of estragole
514to induce carcinogenesis in humans remains unclear.
515The ability of estragole to cause genotoxicity and, thus, to be
516carcinogenic was ﬁrst described byDrinkwater78 and then followed
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517 by numerous in vivo and in vitro studies.74,76,7990 It was found
518 that estragole possesses tissue-, species-, and sex-speciﬁc carcino-
519 genic eﬀects.
520 According to recent evidence, estragole does not have a direct
521 carcinogenic action. The essential factor for estragole’s carcino-
522 genicity is its metabolic activation, leading to the formation of
523 unstable molecules and active radicals that form adducts with
524 nucleic acids and thus damage DNA (genotoxic eﬀect). Estragole
525 metabolism (see Figure 2F2 ) is dose-dependent, and elevated doses
526 of estragole increase its biotransformation, leading to the forma-
527 tion of mutagenic metabolites.91
528 The biotransformation of the same substances can diﬀer in
529 animals and in humans, which raises the question of whether the
530 mutagenic metabolites of estragole are formed in humans. The
531 results of the recent study by Punt,75 which was dedicated to
532 examining in vitro metabolic pathways of estragole in humans,
533 demonstrate a signiﬁcant prevalence of detoxiﬁcation (oxidation) of
534 10-hydroxyestragole compared to the reaction rate of its formation in
535 99% of the human population.75 Thus, the probability of the
536 formation of estragole metabolites that directly damage DNA is
537 low. Consequently, in humans the risk of it acting as a carcinogen is
538 extremely small.93 This was also conﬁrmed by Zeller et al. in their
539 study of estragole metabolism in people consuming fennel tea.92
540 Nevertheless, the available data cannot completely exclude the
541 possibility of the formation of genotoxic metabolites in humans.
542 Moreover, 1-sulfooxyestragole cannot be detected directly in biolo-
543 gical ﬂuids due to its high reactivity and instability.92 Of note,
544 estragole has been demonstrated to be genotoxic and carcinogenic,
545 but the European Commission did not establish a safe exposure
546 limit. The committee was unable to estimate the relative contribu-
547 tions to total exposure to estragole from food containing herbs and
548spices or from the use of added ﬂavorings; however, reductions in
549the compound’s consumption were advised.
550Methyleugenol. Methyleugenol (1,2-dimethoxy-4-prop-2-
551en-1-ylbenzene) is another common component of A. dracun-
552culus essential oil and considered to be potentially toxic. This is
553another topic addressed in the EU Commission opinion.94 It is
554a multisite, multispecies carcinogen, which induces different
555types of liver tumors as well as neuro-endocrine tumors in the
556glandular stomach in both mice and rats. In rats, other types of
557tumors include neoplasms in the forestomach, kidney, mam-
558mary gland, and subcutaneous tissue as well as mesotheliomas.
559Tumors were observed at the lowest used dose of methyleugenol
560(37 mg/kg body weight/day). By analogy with estragole, this is
561probably due to insufficientmetabolic activation.Methyleugenol has
562also demonstrated genotoxicity. A consumption threshold was not
563established for methyleugenol, although reductions in exposure and
564restrictions in use levels are indicated by the commission.
565’EXTRACTS
566Whereas estragole and methyleugenol as individual compounds
567might be toxic, water and wateralcohol extracts of A. dracunculus
568showed no acute toxicity in rodents, with a maximum tolerated dose
569up to 200 mL of extract (1:10)/kg body weight.12,13 Additionally,
570Ribnicky60 reported no mutagenic activity of the ethanolic extract at
5711000 mg/kg in rodents.60 Gross necropsy and clinical chemistry did
572not reveal any eﬀects on organ mass or blood chemistry, and micro-
573scopic examinations found no lesions associated with treatment.
574Overall, using adequate production procedures, the amount of
575potentially harmful compounds (estragole and methyleugenol) in
576extracts can be limited without aﬀecting the overall pharmacological
Figure 2. Metabolism of estragole (adapted from ref 91).
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577 activities of these preparations, that is, using water extracts with
578 low estragole and methyleugenol content and avoiding ethanolic
579 extracts (S. E. Wein€ohrl, B. Feistel, I. Pischel, B. Kopp, and
580 V. Butterweck. Comparative evaluation of two diﬀerent Artemisia
581 dracunculus L. cultivars for blood sugar lowering eﬀects in rats.
582 Submitted for publication to Phytotherapy Research; Doi: 10.1002/
583 PTR.3605.
584 ’CURRENT INTELLECTUAL PROPERTY STATUS
585 A search of the patent database of the European Patent Oﬃce96
586 yielded a total of 1582 hits for the query “Artemisia” and 159 for
587 “tarragon”, whereas the term “Artemisia dracunculus” gave 14 hits
588 and “Russian tarragon” 4 hits.
589 The intellectual property documents (“Artemisia dracunculus”
590 14 and “Russian tarragon” 4 hits) mainly refer to blends of several
591 plants or botanical products, such as essential oils of aromatic
592 herbs. Of the 14 patent hits for “Artemisia dracunculus”, 4 are
593 related to food and ﬂavoring purposes and another 4 to external
594 use (cosmetic or personal care applications). The remaining 6
595 hits and the 2 additional hits for the database query “Russian
596 tarragon” claim medicinal or biofunctional beneﬁts regarding
597 lowering of blood glucose levels, in particular for type II diabetes,
598 and weight loss. Only 3 of them, which were ﬁlled recently,
599 disclose the sole use of Russian tarragon or its extract.9799
600 ’ECONOMIC IMPORTANCE
601 In many countries, cultivation and culinary uses of French
602 tarragon are described. It is said to be a tasty, very aromatic, and
603 valuable herb, whereas the Russian cultivar’s culinary character-
604 istics are given as bitter herb, leading to the opinion that
605 “Russian” tarragon is of no commercial value.100 It is used, fresh
606 or dried, as a gourmet herb in French cooking and as a popular
607 herb in other European countries. In general, all information
608 refers to the essential oil-producing French tarragon, with its
609 main constituent estragole. It is an ingredient in diverse com-
610 mercial preparations including vinegar, mustard, liqueurs, and
611 perfumes. The essential oil of A. dracunculus is included in similar
612 commercial products.
613 In Europe it is one of the 20 most commonly grown herbs. The
614 publicly available market data on prices mainly of fresh French
615 tarragon in the United States and Europe vary between ca. $15
616 and 25/kg in 20082010.101 In 2004 in the European Union
617 A. dracunculuswas cultivated over an area of 236 ha (3 ha of this are
618 organic).102 In the early 1990s, France was the second main
619 European producer, with 310 ha underA. dracunculus cultivation.103
620 ’DISCUSSION
621 A. dracunculus has a long history of traditional use, and a
622 growing number of studies conﬁrm this species' beneﬁcial medi-
623 cinal properties. Alongside available scientiﬁc papers, this review
624 includes a number of studies that are not well-known inter-
625 nationally, most importantly from Soviet and Russian sources.
626 Compared to other health foods and spices, considerable in vivo
627 data are available for A. dracunculus (mostly in Russian). In
628 particular, investigation of the hypoglycemic activity and poten-
629 tial use of A. dracunculus in type II diabetes deserves increased
630 attention.
631 Existing problems with the classiﬁcation of A. dracunculus
632 are mainly associated with incorrect identiﬁcation or impro-
633 per taxonomic classiﬁcation and with the levels of polyploidy.
634Thus, the source of the plant material and a full taxonomic
635description are essential in the investigation of its pharmacolo-
636gical activity, as various cytotypes accumulate divergent phyto-
637chemical proﬁles, thus having diﬀerent biological activities.
638Estragole and methyleugenol, two of the main components of
639A. dracunculus essential oil, were shown to be toxic in rodents.
640However, estragole’s quantities in the essential oil of Russian
641tarragon are considerably lower than in the French tarragon
642(<10% vs up to 75%, respectively). At the same time a number of
643papers have recorded no toxicity for A. dracunculus extracts when
644studied in mice. Moreover, water extracts of A. dracunculus were
645shown to lack both estragole and methyleugenol and, hence, are
646considered to be “safer” than ethanolic extracts. Overall, because
647A. dracunculus is normally used as a spice or a tea, the maximum
648daily dose of dry plant material will be below 10 g/day, which
649corresponds to minor amounts of estragole and methyleugenol.
650Several in vivo studies claim beneﬁcial pharmacological activ-
651ities of A. dracunculus preparations, including anti-inﬂammatory,
652hepatoprotective, antihyperglycemic, and hypolipidaemic ac-
653tions; however, most of the reported eﬀects have been evaluated
654in rodents, and only one study involved healthy men in a
655randomized double-blind trial.69 Therefore, additional research
656involving a larger number of subjects is needed for conﬁrmation
657of the active principles of A. dracunculus preparations.
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